The Enterprise Value as of September 2024 (TTM) for Procaps Group S.A. (PROC) is 476.58M

According to Procaps Group S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 476.58M. This represents a change of -32.08% compared to the average of 701.67M of the last 4 quarters.

Procaps Group S.A. (PROC) Historical Enterprise Value (quarterly & annually)

How has PROC Enterprise Value performed in the past?

The mean historical Enterprise Value of Procaps Group S.A. over the last ten years is 1.27B. The current 476.58M Enterprise Value has changed 3.67% with respect to the historical average. Over the past ten years (40 quarters), PROC's Enterprise Value was at its highest in in the June 2021 quarter at 1.61B. The Enterprise Value was at its lowest in in the September 2023 quarter at 638.17M.

Procaps Group S.A. (PROC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Procaps Group S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Procaps Group S.A. (PROC) Average Enterprise Value

How has PROC Enterprise Value performed in the past?

The current Enterprise Value of Procaps Group S.A. (PROC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Procaps Group S.A. (PROC) Enterprise Value vs. Peers

How is PROC’s Enterprise Value compared to its peers?

Procaps Group S.A.’s Enterprise Value is less than Silver Spike Investment Corp. (0), greater than Sihuan Pharmaceutical Holdings Group Ltd. (38.50M), greater than Phibro Animal Health Corporation (201.27M), less than Eagle Pharmaceuticals, Inc. (1.31B), greater than Delta 9 Cannabis Inc. (110.42M), greater than RAMM Pharma Corp. (65.37M), less than City View Green Holdings Inc. (0), greater than Craftport Cannabis Corp. (3.35M), greater than Speakeasy Cannabis Club Ltd. (10.04M), greater than Collegium Pharmaceutical, Inc. (1.75M), less than ANI Pharmaceuticals, Inc. (1.58B), less than Prestige Consumer Healthcare Inc. (1.26B), less than Regencell Bioscience Holdings Limited (4.72B), greater than null (72.42M),

Build a custom stock screener for Procaps Group S.A. (PROC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Procaps Group S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Procaps Group S.A. (PROC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Procaps Group S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.